Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21838909 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
Condition: Malaria
Interventions: Drug: Coarsucam® (artésunate (AS) + amodiaquine (AQ) as fixed dose combination);   Drug: Coartem® (arthemether+ lumefantrine)

Indicates status has not been verified in more than two years